Taro Pharm Inds (TARO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 12-2010 | 03-2010 | 03-2009 | 03-2008 | 03-2007 | |
| Sales | 0 | 89,300 | 0 | 312,950 | 184,120 |
| Cost of Goods | N/A | 37,950 | N/A | 144,470 | 141,930 |
| Gross Profit | N/A | 51,340 | 46,540 | 168,480 | 42,180 |
| Operating Expenses | 0 | 35,310 | 8,850 | 124,210 | 172,070 |
| Operating Income | N/A | 16,990 | -8,850 | 44,740 | -128,950 |
| Interest Expense | 0 | 1,270 | 0 | 0 | 0 |
| Other Income | 0 | -3,970 | 0 | -18,650 | -13,410 |
| Pre-tax Income | 0 | 11,750 | -8,850 | 26,090 | -142,360 |
| Income Tax | N/A | 1,500 | N/A | 4,950 | -1,640 |
| Net Income Continuous | N/A | 44,105 | 60,600 | 33,139 | -102,722 |
| Net Income | $N/A | $10,240 | $60,600 | $21,130 | $-140,720 |
| EPS Basic Total Ops | N/A | 1.12 | 1.31 | 0.61 | -4.80 |
| EPS Basic Continuous Ops | N/A | 1.12 | 1.55 | 0.95 | -3.50 |
| EPS Diluted Total Ops | N/A | 1.09 | 1.27 | 0.60 | -4.80 |
| EPS Diluted Continuous Ops | N/A | 1.09 | 1.50 | 0.94 | -3.48 |
| EBITDA(a) | $N/A | $21,570 | $14,150 | $44,740 | $-128,950 |